封面
市场调查报告书
商品编码
1622338

肿瘤营养市场规模、份额、增长分析、按癌症类型、按营养类型、按配方、按分销渠道、按最终用户、按地区 - 行业预测,2025-2032

Oncology Nutrition Market Size, Share, Growth Analysis, By Cancer Type, By Nutrition Type, By Formulation, By Distribution Channel, By End-User, By Region - Industry Forecast 2025-2032

出版日期: | 出版商: SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格
简介目录

2023年肿瘤营养市场规模为22.2亿美元,从2024年的24.2亿美元成长到2032年的47.8亿美元,复合年增长率预计为8.9%。

由于癌症发病率上升以及人们越来越认识到营养在癌症治疗中的重要作用,全球肿瘤营养市场正在经历强劲增长。随着越来越多的患者接受化疗和放射线治疗,营养缺乏变得越来越普遍,增加了对专门饮食支持来控制症状、维持体重和改善治疗结果的需求。此外,人们越来越认识到营养对降低癌症风险和改善整体健康的影响,这进一步推动了市场扩张。主要相关人员正在积极投资于研发,并推出针对癌症患者独特营养需求的创新产品和服务,为他们在不断变化的市场格局中取得成功做好准备。

目录

介绍

  • 研究目的
  • 调查范围
  • 定义

调查方法

  • 资讯采购
  • 二手资料和主要资料方法
  • 市场规模预测
  • 市场假设与限制

执行摘要

  • 全球市场展望
  • 供需趋势分析
  • 按细分市场的机会分析

市场动态及展望

  • 市场概况
  • 市场规模
  • 市场动态
    • 驱动因素和机会
    • 抑制因素和挑战
  • 波特的分析

主要市场考察

  • 关键成功因素
  • 竞争程度
  • 主要投资机会
  • 市场生态系统
  • 市场吸引力指数(2024年)
  • PESTEL分析
  • 总体经济指标
  • 价值链分析
  • 价格分析
  • 监管环境
  • 案例研究

肿瘤营养市场规模:依癌症类型分类

  • 市场概况
  • 胃肠癌
  • 肺癌
  • 乳癌
  • 血癌
  • 肝癌
  • 其他的

肿瘤营养市场规模:依营养类型

  • 市场概况
  • 经肠营养
    • 标准型
    • 按病种开药
  • 经肠营养
    • 全静脉营养(TPN)
    • 周边静脉营养(PPN)

肿瘤营养市场规模:依配方分类

  • 市场概况
  • 粉末
  • 液体
  • 锭剂

肿瘤营养市场规模:依通路分类

  • 市场概况
  • 医院药房
  • 零售药房
  • 网路药房

肿瘤营养市场规模:依最终用户分类

  • 市场概况
  • 医院
  • 居家照护设置
  • 专科诊所

肿瘤营养市场规模

  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 德国
    • 西班牙
    • 法国
    • 英国
    • 义大利
    • 其他欧洲国家地区
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 其他拉丁美洲地区
  • 中东/非洲
    • 海湾合作委员会国家
    • 南非
    • 其他中东/非洲

竞争资讯

  • 前5名企业对比
  • 主要企业市场定位(2024年)
  • 主要市场参与者所采取的策略
  • 近期市场趋势
  • 公司市场占有率分析(2024年)
  • 主要企业简介
    • 公司简介
    • 产品系列分析
    • 按细分市场分類的份额分析
    • 收益与前一年同期比较(2022-2024)

主要企业简介

  • Nestle Health Science(Switzerland)
  • Abbott Laboratories(USA)
  • Danone SA(France)
  • Fresenius Kabi AG(Germany)
  • B. Braun Melsungen AG(Germany)
  • Mead Johnson Nutrition Company(USA)
  • Hormel Foods Corporation(USA)
  • Meiji Holdings Co., Ltd.(Japan)
  • Victus, Inc.(USA)
  • Global Health Products, Inc.(USA)
  • Nutritional Medicinals, LLC(USA)
  • Kate Farms(USA)
  • Ajinomoto Co., Inc.(Japan)
  • Abbott Nutrition(USA)
  • Danone Nutricia(Netherlands)
  • Fresenius SE & Co. KGaA(Germany)
  • Baxter International Inc.(USA)
  • Nutritional Resources Inc.(USA)

结论和建议

简介目录
Product Code: SQMIG35D2089

Oncology Nutrition Market size was valued at USD 2.22 Billion in 2023 and is poised to grow from USD 2.42 Billion in 2024 to USD 4.78 Billion by 2032, growing at a CAGR of 8.9% during the forecast period (2025-2032).

The global oncology nutrition market is experiencing robust growth, fueled by the escalating incidence of cancer and the increasing acknowledgment of nutrition's crucial role in cancer care. As more patients undergo chemotherapy and radiation therapy, nutritional deficiencies become prevalent, intensifying the need for specialized dietary support aimed at symptom management, weight maintenance, and better treatment outcomes. Moreover, the rising awareness surrounding nutrition's influence in mitigating cancer risks and enhancing overall health further propels market expansion. Key industry stakeholders are actively investing in research and development to launch innovative oncology nutrition products and services tailored to the unique nutritional requirements of cancer patients, positioning themselves for success in this evolving market landscape.

Top-down and bottom-up approaches were used to estimate and validate the size of the Oncology Nutrition market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Oncology Nutrition Market Segmental Analysis

Global Oncology Nutrition Market is segmented by cancer type, nutrition type, formulation, distribution channel, end-user and region. Based on cancer type, the market is segmented into gastrointestinal cancer, lung cancer, breast cancer, blood cancer, liver cancer and others. Based on nutrition type, the market is segmented into enteral nutrition and parenteral nutrition. Based on formulation, the market is segmented into powder, liquid and tablet. Based on distribution channel, the market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. Based on end-user, the market is segmented into hospitals, homecare settings and specialty clinics. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Oncology Nutrition Market

A significant driver of the oncology nutrition market is the rising global incidence of cancer, which necessitates effective supportive care. Cancer patients frequently face nutritional deficiencies and weight loss due to both the illness and the adverse effects of treatments like chemotherapy and radiation. As a result, oncology nutrition products and services are crucial for delivering essential nutrients, alleviating side effects, and enhancing the overall health and quality of life for those affected by cancer. The increasing awareness of the importance of nutrition therapy in comprehensive cancer care is fueling the demand for these specialized products and services, shaping the market's growth.

Restraints in the Oncology Nutrition Market

The oncology nutrition market faces a notable restraint due to the elevated costs associated with its products. These items are typically custom-made, incorporating specific nutrients tailored to the distinct dietary requirements of cancer patients. The expenses linked to research, development, manufacturing, and rigorous quality assurance increase their price beyond that of conventional nutritional supplements. Moreover, the necessity for personalized nutrition plans and tailored counseling services further escalates overall costs. Consequently, the high prices may hinder accessibility and affordability, particularly for patients in lower-income areas or those with limited financial resources. This financial barrier can significantly affect patient care and nutritional support.

Market Trends of the Oncology Nutrition Market

A prominent trend in the global Oncology Nutrition market is the increasing focus on personalized nutrition interventions tailored specifically for cancer patients. As the medical community recognizes the pivotal role of nutrition in cancer management and recovery, there is a surge in demand for customized nutritional support that aligns with each patient's individual needs. This approach leverages advanced diagnostic tools, including genetic profiling and biomarker analysis, to pinpoint specific nutritional deficiencies or requirements tied to individual cancer types and treatment protocols. By optimizing nutritional intake, enhancing immune function, and mitigating treatment-related side effects, personalized oncology nutrition aims to significantly improve patients' overall well-being and quality of life, reflecting the broader shift towards precision medicine in oncology care.

Table of Contents

Introduction

  • Objectives of the Study
  • Scope of the Report
  • Definitions

Research Methodology

  • Information Procurement
  • Secondary & Primary Data Methods
  • Market Size Estimation
  • Market Assumptions & Limitations

Executive Summary

  • Global Market Outlook
  • Supply & Demand Trend Analysis
  • Segmental Opportunity Analysis

Market Dynamics & Outlook

  • Market Overview
  • Market Size
  • Market Dynamics
    • Drivers & Opportunities
    • Restraints & Challenges
  • Porters Analysis
    • Competitive rivalry
    • Threat of substitute
    • Bargaining power of buyers
    • Threat of new entrants
    • Bargaining power of suppliers

Key Market Insights

  • Key Success Factors
  • Degree of Competition
  • Top Investment Pockets
  • Market Ecosystem
  • Market Attractiveness Index, 2024
  • PESTEL Analysis
  • Macro-Economic Indicators
  • Value Chain Analysis
  • Pricing Analysis
  • Regulatory Landscape
  • Case Studies

Global Oncology Nutrition Market Size by Cancer Type & CAGR (2025-2032)

  • Market Overview
  • Gastrointestinal Cancer
  • Lung Cancer
  • Breast Cancer
  • Blood Cancer
  • Liver Cancer
  • Others

Global Oncology Nutrition Market Size by Nutrition Type & CAGR (2025-2032)

  • Market Overview
  • Enteral Nutrition
    • Standard Formulas
    • Disease-Specific Formulas
  • Parenteral Nutrition
    • Total Parenteral Nutrition (TPN)
    • Peripheral Parenteral Nutrition (PPN)

Global Oncology Nutrition Market Size by Formulation & CAGR (2025-2032)

  • Market Overview
  • Powder
  • Liquid
  • Tablet

Global Oncology Nutrition Market Size by Distribution Channel & CAGR (2025-2032)

  • Market Overview
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Oncology Nutrition Market Size by End-User & CAGR (2025-2032)

  • Market Overview
  • Hospitals
  • Homecare Settings
  • Specialty Clinics

Global Oncology Nutrition Market Size & CAGR (2025-2032)

  • North America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • US
    • Canada
  • Europe (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • Germany
    • Spain
    • France
    • UK
    • Italy
    • Rest of Europe
  • Asia Pacific (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • China
    • India
    • Japan
    • South Korea
    • Rest of Asia-Pacific
  • Latin America (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • Brazil
    • Rest of Latin America
  • Middle East & Africa (Cancer Type, Nutrition Type, Formulation, Distribution Channel, End-User)
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa

Competitive Intelligence

  • Top 5 Player Comparison
  • Market Positioning of Key Players, 2024
  • Strategies Adopted by Key Market Players
  • Recent Developments in the Market
  • Company Market Share Analysis, 2024
  • Company Profiles of All Key Players
    • Company Details
    • Product Portfolio Analysis
    • Company's Segmental Share Analysis
    • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

  • Nestle Health Science (Switzerland)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Laboratories (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danone S.A. (France)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius Kabi AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • B. Braun Melsungen AG (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Mead Johnson Nutrition Company (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Hormel Foods Corporation (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Meiji Holdings Co., Ltd. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Victus, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Global Health Products, Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nutritional Medicinals, LLC (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Kate Farms (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Ajinomoto Co., Inc. (Japan)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Abbott Nutrition (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Danone Nutricia (Netherlands)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Fresenius SE & Co. KGaA (Germany)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Baxter International Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments
  • Nutritional Resources Inc. (USA)
    • Company Overview
    • Business Segment Overview
    • Financial Updates
    • Key Developments

Conclusion & Recommendations